NCT00092573已完成3 期
Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 576
- 主要终点
- Tolerability
研究概览
简要总结
The purpose of this study is to assess the cholesterol lowering safety and effectiveness of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).
详细描述
The duration of treatment is 48 weeks.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •High cholesterol and high triglycerides
排除标准
- •Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study
结局指标
主要结局
Tolerability
次要结局
- Plasma LDL-C, HDL-C and triglycerides after 12 weeks.
研究者
相似试验
已完成
3 期
Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)HypercholesterolemiaHypertriglyceridemiaNCT00092560Organon and Co587
招募中
不适用
Safety Study of Fenofibrate During PregnancySevere Hypertriglyceridemia During PregnancyNCT05883865First People's Hospital of Hangzhou250
已完成
4 期
Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart DiseaseCoronary Heart DiseaseHyperlipidemiaNCT00552747National Heart Institute, Mexico76
已完成
不适用
Functional evaluation of cholesterol level reduction in humansHealthy adultJPRN-UMIN000048222EP Mediate Co., Ltd.60
已完成
不适用
Efficacy Study on the Lipid-lowering Effect of Plant Sterols and Fish OilHealthyMildly Elevated Cholesterol LevelsNCT01313988Unilever R&D332